University of Vienna, Department of Drug and Natural Product Synthesis, Althanstraße 14, 1090 Vienna, Austria.
Molecules. 2013 Sep 30;18(10):12119-43. doi: 10.3390/molecules181012119.
The MCH receptor has been revealed as a target of great interest in positron emission tomography imaging. The receptor's eponymous substrate melanin-concentrating hormone (MCH) is a cyclic peptide hormone, which is located predominantly in the hypothalamus with a major influence on energy and weight regulation as well as water balance and memory. Therefore, it is thought to play an important role in the pathophysiology of adiposity, which is nowadays a big issue worldwide. Based on the selective and high-affinity MCH receptor 1 antagonist SNAP-7941, a series of novel SNAP derivatives has been developed to provide different precursors and reference compounds for the radiosyntheses of the novel PET radiotracers [(11)C]SNAP-7941 and [(18)F]FE@SNAP. Positron emission tomography promotes a better understanding of physiologic parameters on a molecular level, thus giving a deeper insight into MCHR1 related processes as adiposity.
MCH 受体已被证明是正电子发射断层扫描成像中一个非常有趣的靶点。该受体的同名底物黑色素浓缩激素(MCH)是一种环状肽激素,主要位于下丘脑,对能量和体重调节、水平衡和记忆有重要影响。因此,它被认为在肥胖症的病理生理学中发挥着重要作用,而肥胖症是当今全球的一个大问题。基于选择性和高亲和力的 MCH 受体 1 拮抗剂 SNAP-7941,已经开发了一系列新型 SNAP 衍生物,为新型 PET 放射性示踪剂 [(11)C]SNAP-7941 和 [(18)F]FE@SNAP 的放射性合成提供了不同的前体和参比化合物。正电子发射断层扫描促进了对分子水平上生理参数的更好理解,从而深入了解与肥胖症相关的 MCHR1 相关过程。